NO20055448L - Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon - Google Patents
Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjonInfo
- Publication number
- NO20055448L NO20055448L NO20055448A NO20055448A NO20055448L NO 20055448 L NO20055448 L NO 20055448L NO 20055448 A NO20055448 A NO 20055448A NO 20055448 A NO20055448 A NO 20055448A NO 20055448 L NO20055448 L NO 20055448L
- Authority
- NO
- Norway
- Prior art keywords
- antidepressant
- depression
- treatment
- combination
- modafinil
- Prior art date
Links
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title abstract 2
- 208000020401 Depressive disease Diseases 0.000 title abstract 2
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 229960001165 modafinil Drugs 0.000 title abstract 2
- 239000002269 analeptic agent Substances 0.000 title 1
- 230000003555 analeptic effect Effects 0.000 title 1
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46994403P | 2003-05-13 | 2003-05-13 | |
| US10/844,135 US20040242698A1 (en) | 2003-05-13 | 2004-05-12 | Analeptic and antidepressant combinations |
| PCT/US2004/015198 WO2004100939A1 (en) | 2003-05-13 | 2004-05-13 | Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055448D0 NO20055448D0 (no) | 2005-11-17 |
| NO20055448L true NO20055448L (no) | 2006-02-01 |
Family
ID=33457162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055448A NO20055448L (no) | 2003-05-13 | 2005-11-17 | Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040242698A1 (pt) |
| EP (1) | EP1633338A1 (pt) |
| JP (1) | JP2007523052A (pt) |
| KR (1) | KR20060023122A (pt) |
| AR (1) | AR047715A1 (pt) |
| AU (1) | AU2004238381A1 (pt) |
| BR (1) | BRPI0411175A (pt) |
| CA (1) | CA2525526A1 (pt) |
| EA (1) | EA200501803A1 (pt) |
| IS (1) | IS8098A (pt) |
| MX (1) | MXPA05012145A (pt) |
| NO (1) | NO20055448L (pt) |
| TW (1) | TW200505426A (pt) |
| WO (1) | WO2004100939A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| US20040229941A1 (en) * | 2003-05-13 | 2004-11-18 | Cephalon, Inc. | Analeptic and antidepressant combinations |
| AR045423A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Combinaciones de analiticos y antidepresivos |
| AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
| US20040229943A1 (en) * | 2003-05-16 | 2004-11-18 | Cephalon Inc | Analeptic and drug combinations |
| US7368591B2 (en) | 2003-09-19 | 2008-05-06 | Cephalon France | Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation |
| AU2008204800A1 (en) * | 2007-01-11 | 2008-07-17 | Braincells, Inc. | Modulation of neurogenesis with use of modafinil |
| US20100160274A1 (en) * | 2007-09-07 | 2010-06-24 | Sharon Sageman | 7-KETO DHEA for Psychiatric Use |
| US20090325999A1 (en) * | 2008-06-27 | 2009-12-31 | Jie Du | Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions |
| US9801865B2 (en) * | 2008-09-24 | 2017-10-31 | The United States Of America As Represented By The Department Of Veteran Affairs | Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation |
| WO2018150276A2 (en) | 2017-02-16 | 2018-08-23 | Universidad San Sebastian | The combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological conditions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
| FR2771004B1 (fr) * | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| US6503950B1 (en) * | 1999-08-23 | 2003-01-07 | David M. Ockert | Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms |
| US20040229941A1 (en) * | 2003-05-13 | 2004-11-18 | Cephalon, Inc. | Analeptic and antidepressant combinations |
| AR045423A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Combinaciones de analiticos y antidepresivos |
| AR045314A1 (es) * | 2003-05-13 | 2005-10-26 | Cephalon Inc | Composiciones farmaceuticas de analepticos y antidepresivos |
| US20040229943A1 (en) * | 2003-05-16 | 2004-11-18 | Cephalon Inc | Analeptic and drug combinations |
-
2004
- 2004-05-12 US US10/844,135 patent/US20040242698A1/en not_active Abandoned
- 2004-05-13 JP JP2006533083A patent/JP2007523052A/ja active Pending
- 2004-05-13 BR BRPI0411175-3A patent/BRPI0411175A/pt not_active IP Right Cessation
- 2004-05-13 WO PCT/US2004/015198 patent/WO2004100939A1/en not_active Ceased
- 2004-05-13 KR KR1020057021554A patent/KR20060023122A/ko not_active Withdrawn
- 2004-05-13 EP EP04761007A patent/EP1633338A1/en not_active Withdrawn
- 2004-05-13 TW TW093113418A patent/TW200505426A/zh unknown
- 2004-05-13 EA EA200501803A patent/EA200501803A1/ru unknown
- 2004-05-13 MX MXPA05012145A patent/MXPA05012145A/es not_active Application Discontinuation
- 2004-05-13 AU AU2004238381A patent/AU2004238381A1/en not_active Abandoned
- 2004-05-13 CA CA002525526A patent/CA2525526A1/en not_active Abandoned
- 2004-05-14 AR ARP040101624A patent/AR047715A1/es not_active Application Discontinuation
-
2005
- 2005-10-27 IS IS8098A patent/IS8098A/is unknown
- 2005-11-17 NO NO20055448A patent/NO20055448L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0411175A (pt) | 2006-07-18 |
| WO2004100939A1 (en) | 2004-11-25 |
| AR047715A1 (es) | 2006-02-15 |
| WO2004100939B1 (en) | 2007-03-01 |
| TW200505426A (en) | 2005-02-16 |
| NO20055448D0 (no) | 2005-11-17 |
| KR20060023122A (ko) | 2006-03-13 |
| JP2007523052A (ja) | 2007-08-16 |
| IS8098A (is) | 2005-10-27 |
| US20040242698A1 (en) | 2004-12-02 |
| MXPA05012145A (es) | 2006-02-08 |
| AU2004238381A1 (en) | 2004-11-25 |
| EP1633338A1 (en) | 2006-03-15 |
| CA2525526A1 (en) | 2004-11-25 |
| EA200501803A1 (ru) | 2006-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700333A1 (ru) | Терапевтические применения ингибиторов rtp801 | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| ECSP077280A (es) | Moduladores de quinasa de pirrolo-piridina | |
| MX2008006076A (es) | Metodos, composiciones y kits para el tratamiento de condiciones medicas. | |
| BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
| EA200900040A1 (ru) | Молекулы антител, которые связываются с человеческим il-17 | |
| CY1113154T1 (el) | Συνδυασμος του αναληπτικου modafinil και ενος αντικαταθλιπτικου για τη θεραπεια της καταθλιψης | |
| EA201001695A1 (ru) | Применение эпотилона d для лечения заболеваний, связанных с тау-белком | |
| NO20055448L (no) | Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon | |
| DK1505990T3 (da) | Fremgangsmåder til behandling af hepatitis | |
| EA202092720A1 (ru) | Способ увеличения биологической доступности и степени воздействия активатора потенциалзависимых калиевых каналов | |
| BRPI0506449A (pt) | utilização de espilantol e processo de tratamento cosmético de rugas | |
| CY1111285T1 (el) | Θεραπεια αυτοανοσων ασθενειων | |
| MY135829A (en) | Analeptic and drug combinations | |
| JOP20210245A1 (ar) | طرق لعلاج الداء النشواني من النوع خفيف السلسلة | |
| TW200507840A (en) | Method of treating multiple myeloma | |
| TW200509895A (en) | Analeptic and antidepressant combinations | |
| JOP20210217A1 (ar) | طرق لعلاج ألم سطح عين | |
| TW200509894A (en) | Analeptic and antidepressant combinations | |
| DK1610864T3 (da) | Elektromagnetisk stimulering af patienter med osteoporose | |
| DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
| EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
| ATE382092T1 (de) | Screeningverfahren für orthopoxvirus-antivirale mittel | |
| EA200501259A1 (ru) | Комбинированное применение фибрата и орлистата для лечения ожирения |